These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2435417)

  • 1. The design of cytotoxic-agent-antibody conjugates.
    Ghose T; Blair AH
    Crit Rev Ther Drug Carrier Syst; 1987; 3(4):263-359. PubMed ID: 2435417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of monoclonal antibody-drug conjugates in colorectal carcinoma].
    Takahashi T; Sakita M; Yamaguchi T; Kitamura K; Hata K; Noguchi A
    Gan To Kagaku Ryoho; 1988 May; 15(5):1702-9. PubMed ID: 2967049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects.
    Ghose T; Blair AH
    J Natl Cancer Inst; 1978 Sep; 61(3):657-76. PubMed ID: 80453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Missile therapy using monoclonal antibody drug conjugates in colorectal carcinoma].
    Takahashi T; Yamaguchi T; Yokota T; Kitamura K; Suzuyama H; Honda M; Otsuji E; Sawai K; Sakita M; Kotanagi H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):931-7. PubMed ID: 2952068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Targeting of antitumor drugs with monoclonal antibodies].
    Monneret C; Florent JC
    Bull Cancer; 2000 Nov; 87(11):829-38. PubMed ID: 11125291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations.
    Pimm MV
    Crit Rev Ther Drug Carrier Syst; 1988; 5(3):189-227. PubMed ID: 3060267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody therapy of cancer.
    Weiner LM
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):43-51. PubMed ID: 10561017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.
    Seon BK
    Cancer Res; 1984 Jan; 44(1):259-64. PubMed ID: 6606488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugates of mitomycin C with the immunoglobulin M monomer fragment of a monoclonal anti-MM46 immunoglobulin M antibody with or without serum albumin as intermediary.
    Umemoto N; Kato Y; Takeda Y; Saito M; Hara T; Seto M; Takahashi T
    J Appl Biochem; 1984; 6(5-6):297-307. PubMed ID: 6443109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies as carriers for delivering cytotoxic agents.
    Ménard S; Canevari S; Colnaghi MI
    Ann Ist Super Sanita; 1991; 27(1):87-9. PubMed ID: 1958032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-cytotoxic agent conjugates for cancer therapy.
    Chen J; Jaracz S; Zhao X; Chen S; Ojima I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):873-90. PubMed ID: 16296784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor activity of mitomycin C conjugated with anti-alpha-fetoprotein antibody by a novel method of conjugation.
    Kato Y; Tsukada Y; Hara T; Hirai H
    J Appl Biochem; 1983; 5(4-5):313-9. PubMed ID: 6207159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of immunotoxin in cancer therapy; its usefulness and problems in the future].
    Yamaguchi T; Takahashi T; Kitamura K; Noguchi A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1152-6. PubMed ID: 2471454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
    Wang WG; Xu LN; Zhang SH; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1997 Sep; 32(9):669-74. PubMed ID: 11596291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.